🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to determine if cladribine tablets are a safe a...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00213135
Treatments Being Tested
To study the impact of cladribine on peripheral and intrathecal B-cell, pla...
Status
Completed
Location
Barts Health NHS Trust
Start Date
2019-07-01
Trial ID
NCT06415864
The study will include newly-diagnosed AML patients, not suffering acute pr...
Status
Unknown
Location
Weill Cornell Medicine
Start Date
2017-07-03
Trial ID
NCT03257241
Treatments Being Tested
This prospective, multi-center, randomized, controlled Phase II study is to...
Status
Recruiting
Location
The First Affliated Hospital of Soochow University
Start Date
2024-07-29
Trial ID
NCT06532552
Treatments Being Tested
The purpose of this clinical study is to determine the efficacy and safety ...
Status
Recruiting
Location
Arizona Neuroscience Research, LLC
Start Date
2024-06-25
Trial ID
NCT06463587
Treatments Being Tested
The goal of this study was to evaluate the safety, tolerability and effecti...
Status
Completed
Location
Research Site
Start Date
2006-11-30
Trial ID
NCT00436826
Treatments Being Tested
The study will test the effectiveness (rate of complete remissions, total r...
Status
Completed
Location
Community based hemato-oncology medical office
Start Date
2004-06
Trial ID
NCT02157181
Treatments Being Tested
This phase II trial studies how well giving vorinostat, cladribine, and rit...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2008-08
Trial ID
NCT00764517
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Inselspital Bern
Start Date
1998-09
Trial ID
NCT00003746
Treatments Being Tested
Primary Objectives: 1. To determine the response rate, progression-free su...
Status
Completed
Location
U.T.M.D. Anderson Cancer Center
Start Date
1998-03
Trial ID
NCT00483067
Treatments Being Tested